We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

72 hedge funds and large institutions have $212M invested in OptiNose in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $135M → $212M (+$77.2M)

35% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 23

0.16% less ownership

Funds ownership: 4.37%4.2% (-0.16%)

11% less funds holding

Funds holding: 8172 (-9)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
72
Holders Change
-9
Holders Change %
-11.11%
% of All Funds
1.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
31
Reduced
23
Closed
17
Calls
Puts
Net Calls
Net Calls Change

OPTN Hedge Fund Activity: Q2 2020 in Review

72 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2020, worth a combined $212M — up 57% from $135M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of OPTN and 8 opened new positions — a net loss of 9 holders — while 23 trimmed existing stakes and 31 added.

The largest buyer was GMT Capital, adding an estimated $10.9M. The largest seller was JP Morgan Chase, cutting an estimated $13.9M.

  • 72 institutional investors held OptiNose (OPTN) as of Q2 2020, down from 81 in Q1 2020.
  • Funds reported $212M of OptiNose stock for Q2 2020, up 57% quarter-over-quarter.
  • 8 funds opened new OptiNose positions in Q2 2020 and 17 closed out, a net change of -9 holders.
  • The largest OptiNose buyer in Q2 2020 was GMT Capital, an estimated $10.9M added.
  • The largest OptiNose seller in Q2 2020 was JP Morgan Chase, an estimated $13.9M sold.

Based on aggregated 13F filings for Q2 2020.